-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Downgrades Cross Country Healthcare to Neutral, Lowers Price Target to $13.25

Benzinga·05/07/2026 13:28:18
Listen to the news
Wedbush analyst Michael Piccolo downgrades Cross Country Healthcare (NASDAQ:CCRN) from Outperform to Neutral and lowers the price target from $15 to $13.25.